These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8232234)

  • 1. A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.
    Redman RS; Silinsky EM
    Mol Pharmacol; 1993 Oct; 44(4):835-40. PubMed ID: 8232234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors.
    Giniatullin RA; Sokolova EM
    Br J Pharmacol; 1998 Jun; 124(4):839-44. PubMed ID: 9690879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P1-purinoceptors that mediate the prejunctional inhibitory effect of adenosine on capsaicin-sensitive nonadrenergic noncholinergic neurotransmission in the rat mesenteric arterial bed are of the A1 subtype.
    Rubino A; Ralevic V; Burnstock G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1100-4. PubMed ID: 8263771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction.
    Tsentsevitsky A; Kovyazina I; Nikolsky E; Bukharaeva E; Giniatullin R
    Neuroscience; 2013 Sep; 248():699-707. PubMed ID: 23806718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous purines modulate K
    Guarracino JF; Cinalli AR; Veggetti MI; Losavio AS
    J Neurosci Res; 2018 Jun; 96(6):1066-1079. PubMed ID: 29436006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptors modulate high voltage-activated Ca2+ currents and motor pattern generation in the xenopus embryo.
    Brown P; Dale N
    J Physiol; 2000 Jun; 525 Pt 3(Pt 3):655-67. PubMed ID: 10856119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intrinsic modulation of synaptic transmission by ATP in mouse fast twitch muscle.
    Hong SJ; Chang CC
    J Neurophysiol; 1998 Nov; 80(5):2550-8. PubMed ID: 9819262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine inhibits L-type Ca2+ current and catecholamine release in the rabbit carotid body chemoreceptor cells.
    Rocher A; Gonzalez C; Almaraz L
    Eur J Neurosci; 1999 Feb; 11(2):673-81. PubMed ID: 10051768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A₁ and A₂A receptor-mediated modulation of acetylcholine release in the mice neuromuscular junction.
    Garcia N; Priego M; Obis T; Santafe MM; Tomàs M; Besalduch N; Lanuza MA; Tomàs J
    Eur J Neurosci; 2013 Jul; 38(2):2229-41. PubMed ID: 23607735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptors modulate respiratory activity of the neonatal mouse via the cAMP-mediated signaling pathway.
    Mironov SL; Langohr K; Richter DW
    J Neurophysiol; 1999 Jan; 81(1):247-55. PubMed ID: 9914285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.
    Silinsky EM
    J Physiol; 2004 Jul; 558(Pt 2):389-401. PubMed ID: 15146054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1989 Jan; 96(1):211-9. PubMed ID: 2924073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of suramin upon ecto-apyrase activity and synaptic depression of Torpedo electric organ.
    Martí E; Cantí C; Gómez de Aranda I; Miralles F; Solsona C
    Br J Pharmacol; 1996 Jul; 118(5):1232-6. PubMed ID: 8818348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of neuromuscular effects of adenosine by specific adenosine A1-receptor antagonist in live rats.
    Nitahara K; Vizi ES; Shono S; Iihoshi M; Higuchi H; Higa K
    Int J Neurosci; 2005 Mar; 115(3):405-10. PubMed ID: 15804723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of A1-adenosine receptor antagonists on purinergic transmission in the guinea-pig vas deferens in vitro.
    Hardy TA; Brock JA
    Br J Pharmacol; 1999 Apr; 126(8):1761-8. PubMed ID: 10372818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine drives recycled vesicles to a slow-release pool at the mouse neuromuscular junction.
    Perissinotti PP; Uchitel OD
    Eur J Neurosci; 2010 Sep; 32(6):985-96. PubMed ID: 20726887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction.
    De Lorenzo S; Veggetti M; Muchnik S; Losavio A
    Br J Pharmacol; 2004 May; 142(1):113-24. PubMed ID: 15066904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint.
    Dowd E; McQueen DS; Chessell IP; Humphrey PP
    Br J Pharmacol; 1998 Nov; 125(6):1267-71. PubMed ID: 9863656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.